BPC-157: The Wolverine Peptide Ultimate Guide
A synthetic gut‑derived peptide that supercharges tissue repair with a stellar safety profile.
BPC‑157, also called the Wolverine Peptide, is a 15‑amino‑acid fragment naturally produced in the stomach and now synthesized for therapeutic use. Dr. Jason Schuster highlights its remarkable ability to accelerate healing while maintaining an exceptionally high safety margin, making it a standout in the peptide landscape.
Synthetic gut‑derived peptide
In the video Dr. Schuster explains that BPC‑157 is a synthetic formulation of a natural peptide found in gastric juice. It contains 15 amino acids and mirrors the exact molecular structure of the body’s own gastric pentadecapeptide, meaning it is biologically identical to the endogenous compound.
- 15‑amino‑acid sequence derived from stomach secretions
- Identical molecular structure to the body’s natural BPC‑157
- Manufactured in a lab from microbial sources
How it promotes healing
According to Dr. Schuster, BPC‑157 works by up‑regulating vascular endothelial growth factor (VEGF), which drives angiogenesis, tissue regeneration, and neuronal repair. The peptide also supports anti‑inflammatory pathways and can bypass energy deficits by supplying the raw building blocks needed for protein synthesis.
- Increases VEGF → enhanced blood vessel formation
- Stimulates angiogenesis and tissue regeneration
- Facilitates neuronal regrowth after spinal or concussive injury
- Improves mitochondrial efficiency by providing direct peptide substrates
Key health impacts
Dr. Schuster cites multiple animal studies showing BPC‑157’s effectiveness for wound healing, gut health, and recovery from neurological trauma. He notes its potential anti‑inflammatory and even anti‑cancer effects, though he advises caution for patients with active malignancies.
- Accelerates wound and gastrointestinal healing
- Improves recovery from concussions and spinal cord injuries
- Reduces systemic inflammation
- Supports joint, tendon, and ligament repair
- May exhibit anti‑cancer activity, but VEGF up‑regulation warrants medical oversight
Practical guidance
The recommended protocol shared by Dr. Schuster is a subcutaneous injection of 5 mg (0.005 g) two to three times per week, following an eight‑week‑on, eight‑week‑off cycle. He emphasizes the huge safety margin: the lethal dose in animals is about 2 g per kilogram of body weight (≈136 g for a 150‑lb adult), which is roughly 27,000 times the typical therapeutic dose.
- 5 mg subcutaneous injection per dose
- 2‑3× per week
- 8 weeks on, 8 weeks off schedule
- Lethal dose ~136 g for a 150‑lb person (≈27,000× therapeutic dose)
- Avoid or obtain oncologist clearance if you have active cancer
“BPC‑157 is one of the safest, most effective peptides out there, and the agencies trying to ban it know exactly why.”— Dr. Jason Schuster
Go deeper than the summary
Dr. Schuster's board-certified, accredited peptide therapy courses — the full research, dosing, and video breakdowns.